Cargando…

Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years

BACKGROUND: Poor cognitive performance is associated with high vascular risk. However, this association is only investigated in elderly. As neuropathological changes precede clinical symptoms of cognitive impairment by several decades, it is likely that cognitive performance is already associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eersel, Marlise E. A., Joosten, H., Gansevoort, R. T., Slaets, J. P. J., Izaks, G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515561/
https://www.ncbi.nlm.nih.gov/pubmed/30569085
http://dx.doi.org/10.14283/jpad.2018.47
_version_ 1783418109021913088
author van Eersel, Marlise E. A.
Joosten, H.
Gansevoort, R. T.
Slaets, J. P. J.
Izaks, G. J.
author_facet van Eersel, Marlise E. A.
Joosten, H.
Gansevoort, R. T.
Slaets, J. P. J.
Izaks, G. J.
author_sort van Eersel, Marlise E. A.
collection PubMed
description BACKGROUND: Poor cognitive performance is associated with high vascular risk. However, this association is only investigated in elderly. As neuropathological changes precede clinical symptoms of cognitive impairment by several decades, it is likely that cognitive performance is already associated with vascular risk at middle-age. OBJECTIVES: To investigate the association of cognitive performance with treatable vascular risk in middle-aged and old persons. DESIGN: Longitudinal study with three measurements during follow-up period of 5.5 years. SETTING: City of Groningen, the Netherlands. PARTICIPANTS: Cohort of 3,572 participants (age range, 35–82 years; mean age, 54 years; men, 52%). EXPOSURE: Treatable vascular risk as defined by treatable components of the Framingham Risk Score for Cardiovascular Disease at the first measurement (diabetes mellitus, smoking, hypercholesterolemia and hypertension). MEASUREMENTS: Change in cognitive performance during follow-up. Cognitive performance was measured with Ruff Figural Fluency Test (RFFT) and Visual Association Test (VAT), and calculated as the average of the standardized RFFT and VAT score per participant. RESULTS: The mean (SD) cognitive performance changed from 0.00 (0.79) at the first measurement to 0.15 (0.83) at second measurement and to 0.39 (0.82) at the third measurement (Ptrend<0.001). This change was negatively associated with treatable vascular risk: the change in cognitive performance between two measurements decreased with 0.004 per one-point increment of treatable vascular risk (95%CI, -0.008 to 0.000; P=0.05) and with 0.006 per one-year increment of age (95%CI, -0.008 to -0.004; P<0.001). CONCLUSIONS: Change in cognitive performance was associated with treatable vascular risk in persons aged 35 years or older. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.14283/jpad.2018.47 and is accessible for authorized users.
format Online
Article
Text
id pubmed-6515561
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-65155612019-06-05 Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years van Eersel, Marlise E. A. Joosten, H. Gansevoort, R. T. Slaets, J. P. J. Izaks, G. J. J Prev Alzheimers Dis Original Research BACKGROUND: Poor cognitive performance is associated with high vascular risk. However, this association is only investigated in elderly. As neuropathological changes precede clinical symptoms of cognitive impairment by several decades, it is likely that cognitive performance is already associated with vascular risk at middle-age. OBJECTIVES: To investigate the association of cognitive performance with treatable vascular risk in middle-aged and old persons. DESIGN: Longitudinal study with three measurements during follow-up period of 5.5 years. SETTING: City of Groningen, the Netherlands. PARTICIPANTS: Cohort of 3,572 participants (age range, 35–82 years; mean age, 54 years; men, 52%). EXPOSURE: Treatable vascular risk as defined by treatable components of the Framingham Risk Score for Cardiovascular Disease at the first measurement (diabetes mellitus, smoking, hypercholesterolemia and hypertension). MEASUREMENTS: Change in cognitive performance during follow-up. Cognitive performance was measured with Ruff Figural Fluency Test (RFFT) and Visual Association Test (VAT), and calculated as the average of the standardized RFFT and VAT score per participant. RESULTS: The mean (SD) cognitive performance changed from 0.00 (0.79) at the first measurement to 0.15 (0.83) at second measurement and to 0.39 (0.82) at the third measurement (Ptrend<0.001). This change was negatively associated with treatable vascular risk: the change in cognitive performance between two measurements decreased with 0.004 per one-point increment of treatable vascular risk (95%CI, -0.008 to 0.000; P=0.05) and with 0.006 per one-year increment of age (95%CI, -0.008 to -0.004; P<0.001). CONCLUSIONS: Change in cognitive performance was associated with treatable vascular risk in persons aged 35 years or older. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.14283/jpad.2018.47 and is accessible for authorized users. Springer International Publishing 2018-12-14 2019 /pmc/articles/PMC6515561/ /pubmed/30569085 http://dx.doi.org/10.14283/jpad.2018.47 Text en © The Author(s) 2018 Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
spellingShingle Original Research
van Eersel, Marlise E. A.
Joosten, H.
Gansevoort, R. T.
Slaets, J. P. J.
Izaks, G. J.
Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
title Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
title_full Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
title_fullStr Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
title_full_unstemmed Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
title_short Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years
title_sort treatable vascular risk and cognitive performance in persons aged 35 years or older: longitudinal study of six years
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515561/
https://www.ncbi.nlm.nih.gov/pubmed/30569085
http://dx.doi.org/10.14283/jpad.2018.47
work_keys_str_mv AT vaneerselmarliseea treatablevascularriskandcognitiveperformanceinpersonsaged35yearsorolderlongitudinalstudyofsixyears
AT joostenh treatablevascularriskandcognitiveperformanceinpersonsaged35yearsorolderlongitudinalstudyofsixyears
AT gansevoortrt treatablevascularriskandcognitiveperformanceinpersonsaged35yearsorolderlongitudinalstudyofsixyears
AT slaetsjpj treatablevascularriskandcognitiveperformanceinpersonsaged35yearsorolderlongitudinalstudyofsixyears
AT izaksgj treatablevascularriskandcognitiveperformanceinpersonsaged35yearsorolderlongitudinalstudyofsixyears